Financial Fraud Law

Recent Posts

Lidoderm Settlement Costs Endo Pharmaceuticals $192.7 Million
Posted on 21 Feb 2014 by Steven A. Meyerowitz

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not... Read More